Title 40

Volume 35 CHAPTER I SUBCHAP R

Subchapter R - Toxic Substances Control Act (continued)

40:35.0.1.1.1PART 790
PART 790 - PROCEDURES GOVERNING TESTING CONSENT AGREEMENTS AND TEST RULES
40:35.0.1.1.1.1SUBPART A
Subpart A - General Provisions
40:35.0.1.1.1.1.1.1SECTION 790.1
     790.1 Scope, purpose, and authority.
40:35.0.1.1.1.1.1.2SECTION 790.2
     790.2 Applicability.
40:35.0.1.1.1.1.1.3SECTION 790.3
     790.3 Definitions.
40:35.0.1.1.1.1.1.4SECTION 790.5
     790.5 Submission of information.
40:35.0.1.1.1.1.1.5SECTION 790.7
     790.7 Confidentiality.
40:35.0.1.1.1.2SUBPART B
Subpart B - Procedures for Developing Consent Agreements and Test Rules
40:35.0.1.1.1.2.1.1SECTION 790.20
     790.20 Recommendation, recommendation with an intent to designate, and designation of testing candidates by the ITC.
40:35.0.1.1.1.2.1.2SECTION 790.22
     790.22 Procedures for developing consent agreements.
40:35.0.1.1.1.3SUBPART C
Subpart C - Implementation, Enforcement, and Modification of Test Rules
40:35.0.1.1.1.3.1.1SECTION 790.40
     790.40 Promulgation of test rules.
40:35.0.1.1.1.3.1.2SECTION 790.42
     790.42 Persons subject to a test rule.
40:35.0.1.1.1.3.1.3SECTION 790.45
     790.45 Submission of letter of intent to conduct testing or exemption application.
40:35.0.1.1.1.3.1.4SECTION 790.48
     790.48 Procedure if no one submits a letter of intent to conduct testing.
40:35.0.1.1.1.3.1.5SECTION 790.50
     790.50 Submission of study plans.
40:35.0.1.1.1.3.1.6SECTION 790.52
     790.52 Phase II test rule.
40:35.0.1.1.1.3.1.7SECTION 790.55
     790.55 Modification of test standards or schedules during conduct of test.
40:35.0.1.1.1.3.1.8SECTION 790.59
     790.59 Failure to comply with a test rule.
40:35.0.1.1.1.4SUBPART D
Subpart D - Implementation, Enforcement and Modification of Consent Agreements
40:35.0.1.1.1.4.1.1SECTION 790.60
     790.60 Contents of consent agreements.
40:35.0.1.1.1.4.1.2SECTION 790.62
     790.62 Submission of study plans and conduct of testing.
40:35.0.1.1.1.4.1.3SECTION 790.65
     790.65 Failure to comply with a consent agreement.
40:35.0.1.1.1.4.1.4SECTION 790.68
     790.68 Modification of consent agreements.
40:35.0.1.1.1.5SUBPART E
Subpart E - Exemptions From Test Rules
40:35.0.1.1.1.5.1.1SECTION 790.80
     790.80 Submission of exemption applications.
40:35.0.1.1.1.5.1.2SECTION 790.82
     790.82 Content of exemption application.
40:35.0.1.1.1.5.1.3SECTION 790.85
     790.85 Submission of equivalence data.
40:35.0.1.1.1.5.1.4SECTION 790.87
     790.87 Approval of exemption applications.
40:35.0.1.1.1.5.1.5SECTION 790.88
     790.88 Denial of exemption application.
40:35.0.1.1.1.5.1.6SECTION 790.90
     790.90 Appeal of denial of exemption application.
40:35.0.1.1.1.5.1.7SECTION 790.93
     790.93 Termination of conditional exemption.
40:35.0.1.1.1.5.1.8SECTION 790.97
     790.97 Hearing procedures.
40:35.0.1.1.1.5.1.9SECTION 790.99
     790.99 Statement of financial responsibility.
40:35.0.1.1.2PART 791
PART 791 - DATA REIMBURSEMENT
40:35.0.1.1.2.1SUBPART A
Subpart A - General Provisions
40:35.0.1.1.2.1.1.1SECTION 791.1
     791.1 Scope and authority.
40:35.0.1.1.2.1.1.2SECTION 791.2
     791.2 Applicability.
40:35.0.1.1.2.1.1.3SECTION 791.3
     791.3 Definitions.
40:35.0.1.1.2.2SUBPART B
Subpart B - Hearing Procedures
40:35.0.1.1.2.2.1.1SECTION 791.20
     791.20 Initiation of reimbursement proceeding.
40:35.0.1.1.2.2.1.2SECTION 791.22
     791.22 Consolidation of hearings.
40:35.0.1.1.2.2.1.3SECTION 791.27
     791.27 Pre-hearing preparation.
40:35.0.1.1.2.2.1.4SECTION 791.29
     791.29 Appointment of hearing officer.
40:35.0.1.1.2.2.1.5SECTION 791.30
     791.30 Hearing procedures.
40:35.0.1.1.2.2.1.6SECTION 791.31
     791.31 Expedited procedures.
40:35.0.1.1.2.2.1.7SECTION 791.34
     791.34 Serving of notice.
40:35.0.1.1.2.2.1.8SECTION 791.37
     791.37 The award.
40:35.0.1.1.2.2.1.9SECTION 791.39
     791.39 Fees and expenses.
40:35.0.1.1.2.3SUBPART C
Subpart C - Basis for Proposed Order
40:35.0.1.1.2.3.1.1SECTION 791.40
     791.40 Basis for the proposed order.
40:35.0.1.1.2.3.1.2SECTION 791.45
     791.45 Processors.
40:35.0.1.1.2.3.1.3SECTION 791.48
     791.48 Production volume.
40:35.0.1.1.2.3.1.4SECTION 791.50
     791.50 Costs.
40:35.0.1.1.2.3.1.5SECTION 791.52
     791.52 Multiple tests.
40:35.0.1.1.2.4SUBPART D
Subpart D - Review
40:35.0.1.1.2.4.1.1SECTION 791.60
     791.60 Review.
40:35.0.1.1.2.5SUBPART E
Subpart E - Final Order
40:35.0.1.1.2.5.1.1SECTION 791.85
     791.85 Availability of final Agency order.
40:35.0.1.1.2.6SUBPART F
Subpart F - Prohibited Acts
40:35.0.1.1.2.6.1.1SECTION 791.105
     791.105 Prohibited acts.
40:35.0.1.1.3PART 792
PART 792 - GOOD LABORATORY PRACTICE STANDARDS
40:35.0.1.1.3.1SUBPART A
Subpart A - General Provisions
40:35.0.1.1.3.1.1.1SECTION 792.1
     792.1 Scope.
40:35.0.1.1.3.1.1.2SECTION 792.3
     792.3 Definitions.
40:35.0.1.1.3.1.1.3SECTION 792.10
     792.10 Applicability to studies performed under grants and contracts.
40:35.0.1.1.3.1.1.4SECTION 792.12
     792.12 Statement of compliance or non-compliance.
40:35.0.1.1.3.1.1.5SECTION 792.15
     792.15 Inspection of a testing facility.
40:35.0.1.1.3.1.1.6SECTION 792.17
     792.17 Effects of non-compliance.
40:35.0.1.1.3.2SUBPART B
Subpart B - Organization and Personnel
40:35.0.1.1.3.2.1.1SECTION 792.29
     792.29 Personnel.
40:35.0.1.1.3.2.1.2SECTION 792.31
     792.31 Testing facility management.
40:35.0.1.1.3.2.1.3SECTION 792.33
     792.33 Study director.
40:35.0.1.1.3.2.1.4SECTION 792.35
     792.35 Quality assurance unit.
40:35.0.1.1.3.3SUBPART C
Subpart C - Facilities
40:35.0.1.1.3.3.1.1SECTION 792.41
     792.41 General.
40:35.0.1.1.3.3.1.2SECTION 792.43
     792.43 Test system care facilities.
40:35.0.1.1.3.3.1.3SECTION 792.45
     792.45 Test system supply facilities.
40:35.0.1.1.3.3.1.4SECTION 792.47
     792.47 Facilities for handling test, control, and reference substances.
40:35.0.1.1.3.3.1.5SECTION 792.49
     792.49 Laboratory operation areas.
40:35.0.1.1.3.3.1.6SECTION 792.51
     792.51 Specimen and data storage facilities.
40:35.0.1.1.3.4SUBPART D
Subpart D - Equipment
40:35.0.1.1.3.4.1.1SECTION 792.61
     792.61 Equipment design.
40:35.0.1.1.3.4.1.2SECTION 792.63
     792.63 Maintenance and calibration of equipment.
40:35.0.1.1.3.5SUBPART E
Subpart E - Testing Facilities Operation
40:35.0.1.1.3.5.1.1SECTION 792.81
     792.81 Standard operating procedures.
40:35.0.1.1.3.5.1.2SECTION 792.83
     792.83 Reagents and solutions.
40:35.0.1.1.3.5.1.3SECTION 792.90
     792.90 Animal and other test system care.
40:35.0.1.1.3.6SUBPART F
Subpart F - Test, Control, and Reference Substances
40:35.0.1.1.3.6.1.1SECTION 792.105
     792.105 Test, control, and reference substance characterization.
40:35.0.1.1.3.6.1.2SECTION 792.107
     792.107 Test, control, and reference substance handling.
40:35.0.1.1.3.6.1.3SECTION 792.113
     792.113 Mixtures of substances with carriers.
40:35.0.1.1.3.7SUBPART G
Subpart G - Protocol for and Conduct of A Study
40:35.0.1.1.3.7.1.1SECTION 792.120
     792.120 Protocol.
40:35.0.1.1.3.7.1.2SECTION 792.130
     792.130 Conduct of a study.
40:35.0.1.1.3.7.1.3SECTION 792.135
     792.135 Physical and chemical characterization studies.
40:35.0.1.1.3.8SUBPART H
Subparts H-I [Reserved]
40:35.0.1.1.3.9SUBPART J
Subpart J - Records and Reports
40:35.0.1.1.3.9.1.1SECTION 792.185
     792.185 Reporting of study results.
40:35.0.1.1.3.9.1.2SECTION 792.190
     792.190 Storage and retrieval of records and data.
40:35.0.1.1.3.9.1.3SECTION 792.195
     792.195 Retention of records.
40:35.0.1.1.4PART 795
PART 795 - PROVISIONAL TEST GUIDELINES
40:35.0.1.1.4.1SUBPART A
Subpart A [Reserved]
40:35.0.1.1.4.2SUBPART B
Subpart B - Provisional Chemical Fate Guidelines
40:35.0.1.1.4.2.1.1SECTION 795.70
     795.70 Indirect photolysis screening test: Sunlight photolysis in waters containing dissolved humic substances.
40:35.0.1.1.4.3SUBPART C
Subpart C - Provisional Environmental Effects Guidelines
40:35.0.1.1.4.3.1.1SECTION 795.120
     795.120 Gammarid acute toxicity test.
40:35.0.1.1.4.4SUBPART D
Subpart D - Provisional Health Effects Guidelines
40:35.0.1.1.4.4.1.1SECTION 795.225
     795.225 Dermal pharmacokinetics of DGBE and DGBA.
40:35.0.1.1.4.4.1.2SECTION 795.228
     795.228 Oral/dermal pharmacokinetics.
40:35.0.1.1.4.4.1.3SECTION 795.231
     795.231 Pharmacokinetics of isopropanal.
40:35.0.1.1.4.4.1.4SECTION 795.232
     795.232 Inhalation and dermal pharmacokinetics of commercial hexane.
40:35.0.1.1.4.4.1.5SECTION 795.250
     795.250 Developmental neurotoxicity screen.
40:35.0.1.1.5PART 796
PART 796 - CHEMICAL FATE TESTING GUIDELINES
40:35.0.1.1.5.1SUBPART A
Subpart A [Reserved]
40:35.0.1.1.5.2SUBPART B
Subpart B - Physical and Chemical Properties
40:35.0.1.1.5.2.1.1SECTION 796.1050
     796.1050 Absorption in aqueous solution: Ultraviolet/visible spectra.
40:35.0.1.1.5.2.1.2SECTION 796.1950
     796.1950 Vapor pressure.
40:35.0.1.1.5.3SUBPART C
Subpart C - Transport Processes
40:35.0.1.1.5.3.1.1SECTION 796.2750
     796.2750 Sediment and soil adsorption isotherm.
40:35.0.1.1.5.4SUBPART D
Subpart D - Transformation Processes
40:35.0.1.1.5.4.1.1SECTION 796.3100
     796.3100 Aerobic aquatic biodegradation.
40:35.0.1.1.5.4.1.2SECTION 796.3500
     796.3500 Hydrolysis as a function of pH at 25 °C.
40:35.0.1.1.6PART 797
PART 797 - ENVIRONMENTAL EFFECTS TESTING GUIDELINES
40:35.0.1.1.6.1SUBPART A
Subpart A [Reserved]
40:35.0.1.1.6.2SUBPART B
Subpart B - Aquatic Guidelines
40:35.0.1.1.6.2.1.1SECTION 797.1050
     797.1050 Algal acute toxicity test.
40:35.0.1.1.6.2.1.2SECTION 797.1300
     797.1300 Daphnid acute toxicity test.
40:35.0.1.1.6.2.1.3SECTION 797.1330
     797.1330 Daphnid chronic toxicity test.
40:35.0.1.1.6.2.1.4SECTION 797.1400
     797.1400 Fish acute toxicity test.
40:35.0.1.1.6.2.1.5SECTION 797.1600
     797.1600 Fish early life stage toxicity test.
40:35.0.1.1.6.2.1.6SECTION 797.1930
     797.1930 Mysid shrimp acute toxicity test.
40:35.0.1.1.6.2.1.7SECTION 797.1950
     797.1950 Mysid shrimp chronic toxicity test.
40:35.0.1.1.7PART 798
PART 798 - HEALTH EFFECTS TESTING GUIDELINES
40:35.0.1.1.7.1SUBPART A
Subparts A-B [Reserved]
40:35.0.1.1.7.2SUBPART C
Subpart C - Subchronic Exposure
40:35.0.1.1.7.2.1.1SECTION 798.2250
     798.2250 Dermal toxicity.
40:35.0.1.1.7.2.1.2SECTION 798.2450
     798.2450 Inhalation toxicity.
40:35.0.1.1.7.2.1.3SECTION 798.2650
     798.2650 Oral toxicity.
40:35.0.1.1.7.3SUBPART D
Subpart D - Chronic Exposure
40:35.0.1.1.7.3.1.1SECTION 798.3260
     798.3260 Chronic toxicity.
40:35.0.1.1.7.3.1.2SECTION 798.3300
     798.3300 Oncogenicity.
40:35.0.1.1.7.3.1.3SECTION 798.3320
     798.3320 Combined chronic toxicity/oncogenicity.
40:35.0.1.1.7.4SUBPART E
Subpart E - Specific Organ/Tissue Toxicity
40:35.0.1.1.7.4.1.1SECTION 798.4100
     798.4100 Dermal sensitization.
40:35.0.1.1.7.4.1.2SECTION 798.4350
     798.4350 Inhalation developmental toxicity study.
40:35.0.1.1.7.4.1.3SECTION 798.4700
     798.4700 Reproduction and fertility effects.
40:35.0.1.1.7.4.1.4SECTION 798.4900
     798.4900 Developmental toxicity study.
40:35.0.1.1.7.5SUBPART F
Subpart F - Genetic Toxicity
40:35.0.1.1.7.5.1.1SECTION 798.5195
     798.5195 Mouse biochemical specific locus test.
40:35.0.1.1.7.5.1.2SECTION 798.5200
     798.5200 Mouse visible specific locus test.
40:35.0.1.1.7.5.1.3SECTION 798.5265
     798.5265 The salmonella typhimurium reverse mutation assay.
40:35.0.1.1.7.5.1.4SECTION 798.5275
     798.5275 Sex-linked recessive lethal test in drosophila melanogaster.
40:35.0.1.1.7.5.1.5SECTION 798.5300
     798.5300 Detection of gene mutations in somatic cells in culture.
40:35.0.1.1.7.5.1.6SECTION 798.5375
     798.5375 In vitro mammalian cytogenetics.
40:35.0.1.1.7.5.1.7SECTION 798.5385
     798.5385 In vivo mammalian bone marrow cytogenetics tests: Chromosomal analysis.
40:35.0.1.1.7.5.1.8SECTION 798.5395
     798.5395 In vivo mammalian bone marrow cytogenetics tests: Micronucleus assay.
40:35.0.1.1.7.5.1.9SECTION 798.5450
     798.5450 Rodent dominant lethal assay.
40:35.0.1.1.7.5.1.10SECTION 798.5460
     798.5460 Rodent heritable translocation assays.
40:35.0.1.1.7.5.1.11SECTION 798.5500
     798.5500 Differential growth inhibition of repair proficient and repair deficient bacteria: “Bacterial DNA damage or repair tests.”
40:35.0.1.1.7.5.1.12SECTION 798.5955
     798.5955 Heritable translocation test in drosophila melanogaster.
40:35.0.1.1.7.6SUBPART G
Subpart G - Neurotoxicity
40:35.0.1.1.7.6.1.1SECTION 798.6050
     798.6050 Functional observational battery.
40:35.0.1.1.7.6.1.2SECTION 798.6200
     798.6200 Motor activity.
40:35.0.1.1.7.6.1.3SECTION 798.6400
     798.6400 Neuropathology.
40:35.0.1.1.7.6.1.4SECTION 798.6500
     798.6500 Schedule-controlled operant behavior.
40:35.0.1.1.7.6.1.5SECTION 798.6560
     798.6560 Subchronic delayed neuro-toxicity of organophosphorus substances.
40:35.0.1.1.8PART 799
PART 799 - IDENTIFICATION OF SPECIFIC CHEMICAL SUBSTANCE AND MIXTURE TESTING REQUIREMENTS
40:35.0.1.1.8.1SUBPART A
Subpart A - General Provisions
40:35.0.1.1.8.1.1.1SECTION 799.1
     799.1 Scope and purpose.
40:35.0.1.1.8.1.1.2SECTION 799.2
     799.2 Applicability.
40:35.0.1.1.8.1.1.3SECTION 799.3
     799.3 Definitions.
40:35.0.1.1.8.1.1.4SECTION 799.5
     799.5 Submission of information.
40:35.0.1.1.8.1.1.5SECTION 799.10
     799.10 Test standards.
40:35.0.1.1.8.1.1.6SECTION 799.11
     799.11 Availability of test guidelines.
40:35.0.1.1.8.1.1.7SECTION 799.12
     799.12 Test results.
40:35.0.1.1.8.1.1.8SECTION 799.17
     799.17 Effects of non-compliance.
40:35.0.1.1.8.1.1.9SECTION 799.18
     799.18 Chemicals subject of test rules or consent orders for which the testing reimbursement period has passed.
40:35.0.1.1.8.1.1.10SECTION 799.19
     799.19 Chemical imports and exports.
40:35.0.1.1.8.2SUBPART B
Subpart B - Specific Chemical Test Rules
40:35.0.1.1.8.2.1.1SECTION 799.1053
     799.1053 Trichlorobenzenes.
40:35.0.1.1.8.2.1.2SECTION 799.1560
     799.1560 Diethylene glycol butyl ether and diethylene glycol butyl ether acetate.
40:35.0.1.1.8.2.1.3SECTION 799.1575
     799.1575 Diethylenetriamine (DETA).
40:35.0.1.1.8.2.1.4SECTION 799.1645
     799.1645 2-Ethylhexanol.
40:35.0.1.1.8.2.1.5SECTION 799.1700
     799.1700 Fluoroalkenes.
40:35.0.1.1.8.2.1.6SECTION 799.2155
     799.2155 Commercial hexane.
40:35.0.1.1.8.2.1.7SECTION 799.2325
     799.2325 Isopropanol.
40:35.0.1.1.8.2.1.8SECTION 799.2475
     799.2475 2-Mercaptobenzothiazole.
40:35.0.1.1.8.2.1.9SECTION 799.2700
     799.2700 Methyl ethyl ketoxime.
40:35.0.1.1.8.2.1.10SECTION 799.3300
     799.3300 Unsubstituted phenylenediamines.
40:35.0.1.1.8.2.1.11SECTION 799.4360
     799.4360 Tributyl phosphate.
40:35.0.1.1.8.2.1.12SECTION 799.4440
     799.4440 Triethylene glycol monomethyl ether.
40:35.0.1.1.8.3SUBPART C
Subpart C - Testing Consent Orders
40:35.0.1.1.8.3.1.1SECTION 799.5000
     799.5000 Testing consent orders for substances and mixtures with Chemical Abstract Service Registry Numbers.
40:35.0.1.1.8.3.1.2SECTION 799.5025
     799.5025 Testing consent orders for mixtures without Chemical Abstracts Service Registry Numbers.
40:35.0.1.1.8.4SUBPART D
Subpart D - Multichemical Test Rules
40:35.0.1.1.8.4.1.1SECTION 799.5055
     799.5055 Hazardous waste constituents subject to testing.
40:35.0.1.1.8.4.1.2SECTION 799.5075
     799.5075 Drinking water contaminants subject to testing.
40:35.0.1.1.8.4.1.3SECTION 799.5085
     799.5085 Chemical testing requirements for first group of high production volume chemicals (HPV1).
40:35.0.1.1.8.4.1.4SECTION 799.5087
     799.5087 Chemical testing requirements for second group of high production volume chemicals (HPV2).
40:35.0.1.1.8.4.1.5SECTION 799.5089
     799.5089 Chemical testing requirements for third group of high production volume chemicals (HPV3).
40:35.0.1.1.8.4.1.6SECTION 799.5115
     799.5115 Chemical testing requirements for certain chemicals of interest to the Occupational Safety and Health Administration.
40:35.0.1.1.8.5SUBPART E
Subpart E - Product Properties Test Guidelines
40:35.0.1.1.8.5.1.1SECTION 799.6755
     799.6755 TSCA partition coefficient (n-octanol/water), shake flask method.
40:35.0.1.1.8.5.1.2SECTION 799.6756
     799.6756 TSCA partition coefficient (n-octanol/water), generator column method.
40:35.0.1.1.8.5.1.3SECTION 799.6784
     799.6784 TSCA water solubility: Column elution method; shake flask method.
40:35.0.1.1.8.5.1.4SECTION 799.6786
     799.6786 TSCA water solubility: Generator column method.
40:35.0.1.1.8.6SUBPART F
Subparts F-G [Reserved]
40:35.0.1.1.8.7SUBPART H
Subpart H - Health Effects Test Guidelines
40:35.0.1.1.8.7.1.1SECTION 799.9110
     799.9110 TSCA acute oral toxicity.
40:35.0.1.1.8.7.1.2SECTION 799.9120
     799.9120 TSCA acute dermal toxicity.
40:35.0.1.1.8.7.1.3SECTION 799.9130
     799.9130 TSCA acute inhalation toxicity.
40:35.0.1.1.8.7.1.4SECTION 799.9135
     799.9135 TSCA acute inhalation toxicity with histopathology.
40:35.0.1.1.8.7.1.5SECTION 799.9305
     799.9305 TSCA Repeated dose 28-day oral toxicity study in rodents.
40:35.0.1.1.8.7.1.6SECTION 799.9310
     799.9310 TSCA 90-day oral toxicity in rodents.
40:35.0.1.1.8.7.1.7SECTION 799.9325
     799.9325 TSCA 90-day dermal toxicity.
40:35.0.1.1.8.7.1.8SECTION 799.9346
     799.9346 TSCA 90-day inhalation toxicity.
40:35.0.1.1.8.7.1.9SECTION 799.9355
     799.9355 TSCA reproduction/developmental toxicity screening test.
40:35.0.1.1.8.7.1.10SECTION 799.9365
     799.9365 TSCA combined repeated dose toxicity study with the reproduction/developmental toxicity screening test.
40:35.0.1.1.8.7.1.11SECTION 799.9370
     799.9370 TSCA prenatal developmental toxicity.
40:35.0.1.1.8.7.1.12SECTION 799.9380
     799.9380 TSCA reproduction and fertility effects.
40:35.0.1.1.8.7.1.13SECTION 799.9410
     799.9410 TSCA chronic toxicity.
40:35.0.1.1.8.7.1.14SECTION 799.9420
     799.9420 TSCA carcinogenicity.
40:35.0.1.1.8.7.1.15SECTION 799.9430
     799.9430 TSCA combined chronic toxicity/carcinogenicity.
40:35.0.1.1.8.7.1.16SECTION 799.9510
     799.9510 TSCA bacterial reverse mutation test.
40:35.0.1.1.8.7.1.17SECTION 799.9530
     799.9530 TSCA in vitro mammalian cell gene mutation test.
40:35.0.1.1.8.7.1.18SECTION 799.9537
     799.9537 TSCA in vitro mammalian chromosome aberration test.
40:35.0.1.1.8.7.1.19SECTION 799.9538
     799.9538 TSCA mammalian bone marrow chromosomal aberration test.
40:35.0.1.1.8.7.1.20SECTION 799.9539
     799.9539 TSCA mammalian erythrocyte micronucleus test.
40:35.0.1.1.8.7.1.21SECTION 799.9620
     799.9620 TSCA neurotoxicity screening battery.
40:35.0.1.1.8.7.1.22SECTION 799.9630
     799.9630 TSCA developmental neurotoxicity.
40:35.0.1.1.8.7.1.23SECTION 799.9748
     799.9748 TSCA metabolism and pharmacokinetics
40:35.0.1.1.8.7.1.24SECTION 799.9780
     799.9780 TSCA immunotoxicity.